Patent ID: 8273711
Filing Date: 2012-09-25
Classification: A61J,A61K,A61P,C07K,Y10S

Abstract:
1. A stable transdermal insulin composition comprising a phosphatidylcholine component, said phosphatidylcholine component comprising polyenylphosphatidylcholine-enriched phosphatidylcholine and at least one polyglycol, and forming a non-liposomal multilamellar liquid crystal carrier entrapping said insulin for transdermal delivery to dermal vasculature, wherein said multilamellar liquid crystal carrier stabilizes the insulin at room temperature, wherein said phosphatidylcholine component comprises 45% w/w phosphatidylcholine, 50% w/w polyglycol having a molecular weight of 200 and 5% w/w polyglycol having a molecular weight of 400.